US 9827223
Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist
granted A61KA61K31/16A61K31/165
Quick answer
US patent 9827223 (Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/16, A61K31/165, A61K31/167, A61K31/357